Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Incurable Solid Malignancy”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Early research (Phase 1)Study completedNCT01004861
What this trial is testing

Safety Study of PLX108-01 in Patients With Solid Tumors

Who this might be right for
Solid Tumor
Daiichi Sankyo 132
Testing effectiveness (Phase 2)Active Not RecruitingNCT03035409
What this trial is testing

Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmC-Reactive Protein MeasurementCancer Fatigue+3 more
M.D. Anderson Cancer Center 129
Not applicableEnded earlyNCT01904916
What this trial is testing

CPCT-05 Biopsy Protocol Patient Selection

Who this might be right for
Solid TumorsMetastatic Disease
P.O. Witteveen 195
Early research (Phase 1)Study completedNCT00390117
What this trial is testing

AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 34
Early research (Phase 1)Active Not RecruitingNCT02537418
What this trial is testing

Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens

Who this might be right for
Solid Malignancies
Canadian Cancer Trials Group 153
Early research (Phase 1)Study completedNCT00443976
What this trial is testing

Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkins LymphomaUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 35
Early research (Phase 1)Study completedNCT00003707
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Cancer

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
The University of Texas Health Science Center at San Antonio 22
Early research (Phase 1)Study completedNCT00024206
What this trial is testing

SU6668 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 12
Early research (Phase 1)Study completedNCT00107250
What this trial is testing

AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)

Who this might be right for
Colorectal CancerLung CancerUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 50
Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Early research (Phase 1)Study completedNCT00676910
What this trial is testing

A Research Study of JNJ-26854165 to Determine the Safety and Dose in Patients With Advanced Stage or Refractory Solid Tumors.

Who this might be right for
Neoplasms
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 71
Testing effectiveness (Phase 2)Active Not RecruitingNCT02285816
What this trial is testing

MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours

Who this might be right for
Advanced/Metastatic Solid Tumours
Canadian Cancer Trials Group 56
Early research (Phase 1)UnknownNCT06054932
What this trial is testing

Safety, Tolerability, and Immunogenicity of LK101 Alone in Participants With Incurable Solid Tumors

Who this might be right for
Advanced Solid Tumor
Beijing Likang Life Science and Tech Co., Ltd. 18
Early research (Phase 1)Study completedNCT00660725
What this trial is testing

Study of GemOx and Vandetanib in Advanced Solid Malignancy

Who this might be right for
Advanced Incurable Solid Malignancy
Leonard Appleman 22
Early research (Phase 1)Study completedNCT04147247
What this trial is testing

A Trial to Find the Safe Dose for BI 905681 in Patients With Incurable Tumours or Tumours That Have Spread

Who this might be right for
Neoplasms
Boehringer Ingelheim 21
Early research (Phase 1)Study completedNCT01393509
What this trial is testing

The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies

Who this might be right for
Metastatic Solid TumorLymphomaMyeloproliferative Neoplasms (MPN)
Memorial Sloan Kettering Cancer Center 47
Early research (Phase 1)Active Not RecruitingNCT04958239
What this trial is testing

Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer

Who this might be right for
Neoplasms
Boehringer Ingelheim 151
Early research (Phase 1)Study completedNCT05702424
What this trial is testing

Evaluation of IGM-7354 in Adults With Relapsed and/or Refractory Cancer

Who this might be right for
Solid Tumor
IGM Biosciences, Inc. 14
Early research (Phase 1)Study completedNCT01525602
What this trial is testing

Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Daiichi Sankyo 74
Early research (Phase 1)Study completedNCT01065025
What this trial is testing

Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies

Who this might be right for
Advanced and Incurable Solid TumorsMalignant Lymphomas
4SC AG 60
Load More Results